Karl O'reilly

Loughborough, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Cultivating Inclusivity and Bridging Gaps Through Reverse Mentoring: A Feasibility Study Within the Royal College of Radiologists.

Cultivating Inclusivity and Bridging Gaps Through Reverse Mentoring: A Feasibility Study Within the Royal College of Radiologists.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: April 25, 2024

Unveiling Disparities: Exploring Differential Attainment in Postgraduate Training Within Clinical Oncology.

Unveiling Disparities: Exploring Differential Attainment in Postgraduate Training Within Clinical Oncology.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: December 18, 2023

Rationale and study protocol of ACQUIRE, a prospective, observational study measuring quality of life, treatment preference and treatment satisfaction of autosomal dominant polycystic kidney disease (ADPKD) patients in Europe.

Rationale and study protocol of ACQUIRE, a prospective, observational study measuring quality of life, treatment preference and treatment satisfaction of autosomal dominant polycystic kidney disease (ADPKD) patients in Europe.

Journal: BMC nephrology

Published: July 22, 2019

Modelling the long-term benefits of tolvaptan therapy on renal function decline in autosomal dominant polycystic kidney disease: an exploratory analysis using the ADPKD outcomes model.

Modelling the long-term benefits of tolvaptan therapy on renal function decline in autosomal dominant polycystic kidney disease: an exploratory analysis using the ADPKD outcomes model.

Journal: BMC nephrology

Published: May 23, 2018

Systematic reviews of economic burden and health-related quality of life in patients with acute myeloid leukemia.

Systematic reviews of economic burden and health-related quality of life in patients with acute myeloid leukemia.

Journal: Cancer treatment reviews

Published: March 08, 2018

A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model.

A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model.

Journal: BMC nephrology

Published: July 27, 2017

A systematic review of known interventions for the treatment of chronic nonhypovolaemic hypotonic hyponatraemia and a meta-analysis of the vaptans.

A systematic review of known interventions for the treatment of chronic nonhypovolaemic hypotonic hyponatraemia and a meta-analysis of the vaptans.

Journal: Clinical endocrinology

Published: May 03, 2016

The burden of illness in patients with hyponatraemia in Sweden: a population-based registry study.

The burden of illness in patients with hyponatraemia in Sweden: a population-based registry study.

Journal: International journal of clinical practice

Published: March 22, 2016

Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in Sweden.

Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in Sweden.

Journal: BMC endocrine disorders

Published: August 04, 2015

A systematic review of the predictors of disease progression in patients with autosomal dominant polycystic kidney disease.

A systematic review of the predictors of disease progression in patients with autosomal dominant polycystic kidney disease.

Journal: BMC nephrology

Published: January 29, 2015

Development Of A Model To Predict Disease Progression In Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Development Of A Model To Predict Disease Progression In Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: November 01, 2014

The Cost-Effectiveness of Tolvaptan for the Treatment of Hyponatraemia Secondary To Syndrome Of Inappropriate Antidiuretic Hormone Secretion in Sweden.

The Cost-Effectiveness of Tolvaptan for the Treatment of Hyponatraemia Secondary To Syndrome Of Inappropriate Antidiuretic Hormone Secretion in Sweden.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: November 01, 2014

Showing 1-12 of 15

Last Updated: 09/26/2026